Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Wendy Broom"'
Autor:
Rosanna K Ma, Pei-Yin Tsai, Alaa R Farghli, Alexandria Shumway, Matt Kanke, John D Gordan, Taranjit S Gujral, Khashayar Vakili, Manabu Nukaya, Leila Noetzli, Sean Ronnekleiv-Kelly, Wendy Broom, Joeva Barrow, Praveen Sethupathy
Publikováno v:
PLoS Genetics, Vol 20, Iss 3, p e1011216 (2024)
Fibrolamellar carcinoma (FLC) is a rare liver cancer that disproportionately affects adolescents and young adults. Currently, no standard of care is available and there remains a dire need for new therapeutics. Most patients harbor the fusion oncogen
Externí odkaz:
https://doaj.org/article/19487cd4b6304631ba2145c57eb9603a
Autor:
Tong Zi, Sriram Sathyanarayanan, Katherine Kirwin, Su Chul Jang, Kyriakos Economides, John Lin, Kelvin Zhang, Shil Patel, Xudong Feng, Sevda Lule, Paloma Sanchez-Jauregui, Samuel Kasera, Silvia Siso, Wendy Broom
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/b9ed0903da974154918e2734159b209f
Autor:
Jessica Baker Flechtner, Thomas A. Davis, Pamela M. Carroll, Charles G. Drake, Kwok-Kin Wong, Elizabeth M. Jaffee, Parul Agnihotri, Wendy Broom, Daniel B. DeOliveira, Kyle Ferber, Emily Tjon, Vijetha Vemulapalli, James J. Foti, Arthur P. DeCillis, Ulka N. Vaishampayan, Mark N. Stein, Maura L. Gillison, Melissa L. Johnson, Przemyslaw Twardowski, Roger B. Cohen, Victoria L. DeVault, Hanna Starobinets, Lisa K. McNeil, Hubert Lam
Neoantigens are critical targets of antitumor T-cell responses. The ATLAS bioassay was developed to identify neoantigens empirically by expressing each unique patient-specific tumor mutation individually in Escherichia coli, pulsing autologous dendri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69391e7bebbc1a1098be422e085f1940
https://doi.org/10.1158/2159-8290.c.6548228.v1
https://doi.org/10.1158/2159-8290.c.6548228.v1
Autor:
Jessica Baker Flechtner, Thomas A. Davis, Pamela M. Carroll, Charles G. Drake, Kwok-Kin Wong, Elizabeth M. Jaffee, Parul Agnihotri, Wendy Broom, Daniel B. DeOliveira, Kyle Ferber, Emily Tjon, Vijetha Vemulapalli, James J. Foti, Arthur P. DeCillis, Ulka N. Vaishampayan, Mark N. Stein, Maura L. Gillison, Melissa L. Johnson, Przemyslaw Twardowski, Roger B. Cohen, Victoria L. DeVault, Hanna Starobinets, Lisa K. McNeil, Hubert Lam
Supplementary Table from An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078f1d611a139d47d9a2839b5a415c3e
https://doi.org/10.1158/2159-8290.22536755
https://doi.org/10.1158/2159-8290.22536755
Autor:
Jessica Baker Flechtner, Thomas A. Davis, Pamela M. Carroll, Charles G. Drake, Kwok-Kin Wong, Elizabeth M. Jaffee, Parul Agnihotri, Wendy Broom, Daniel B. DeOliveira, Kyle Ferber, Emily Tjon, Vijetha Vemulapalli, James J. Foti, Arthur P. DeCillis, Ulka N. Vaishampayan, Mark N. Stein, Maura L. Gillison, Melissa L. Johnson, Przemyslaw Twardowski, Roger B. Cohen, Victoria L. DeVault, Hanna Starobinets, Lisa K. McNeil, Hubert Lam
Supplementary Figure from An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d1af50888ce099e83501cd69eefc22b
https://doi.org/10.1158/2159-8290.22536761.v1
https://doi.org/10.1158/2159-8290.22536761.v1
Autor:
Wendy Broom, Elizabeth M. Jaffee, Daniel DeOliveira, Victoria L. DeVault, Charles G. Drake, Ulka N. Vaishampayan, Arthur P. Decillis, Vijetha Vemulapalli, Maura L. Gillison, Mark N. Stein, Pamela M. Carroll, Kyle Ferber, Parul Agnihotri, Emily Tjon, Hubert Lam, Jessica Flechtner, James Foti, Roger B. Cohen, Lisa K. McNeil, Hanna Starobinets, Melissa Lynne Johnson, Przemyslaw Twardowski, Thomas A. Davis, Kwok-Kin Wong
Publikováno v:
Cancer Discovery. 11:696-713
Neoantigens are critical targets of antitumor T-cell responses. The ATLAS bioassay was developed to identify neoantigens empirically by expressing each unique patient-specific tumor mutation individually in Escherichia coli, pulsing autologous dendri
Autor:
Sriram Sathyanarayanan, John Lin, Shil Patel, Paloma Sanchez-Jauregui, Xudong Feng, Silvia Siso, Kyriakos D. Economides, Wendy Broom, Su Chul Jang, Kelvin Zhang, Samuel Kasera, Tong Zi, Katherine Kirwin, Sevda Lule
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundLeptomeningeal disease (LMD) occurs when cells from primary tumors metastasize to the cerebrospinal fluid (CSF) space leading to multifocal neurological deficits. LMD has an overall prevalence of ~5% in cancer patients, but is most commonly
Autor:
Melissa Hayes, James Loizeaux, James Perry, Jason R. Dobson, Wendy Broom, Mariya Croll, Anna Lyubetskaya, Crystal Cabral, Christopher L. Warren, James Foti, F. Stephen Hodi, Jessica Flechtner, Louisa Dowal
Publikováno v:
Cancer Research. 79:LB-223
Broadly reinvigorating the T cell response by blocking immune-inhibitory receptors can produce durable clinical benefit in 20-40% of melanoma patients. Due to low response rates and potential toxicity of checkpoint therapy, identification of biomarke
Autor:
Wendy Broom, Thao Duong, Elaine Donohue, Pramod Pandey, Jungwook Kim, Patrick S. Doyle, W. Adam Hill, Nakwon Choi, Stephen C. Chapin
Publikováno v:
Analytical Chemistry. 84:9370-9378
Transcriptional profiling, which is directly or indirectly associated with expressed protein levels, has been used in various applications including clinical prognosis and pharmaceutical investigation of drug activities. Although the widely used reve
Publikováno v:
Nurse Prescribing. 8:392-395
This report outlines a small-scale service evaluation carried out in Cornwall Partnership NHS Foundation Trust examining views of staff on non-medical prescribing (NMP). It follows a study conducted prior to the implementation of NMP in the trust, wh